| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $159.4M | — | +10.6% |
| Cost of Revenue | $58.5M | — | +1.4% |
| Gross Profit | $100.9M | — | +16.8% |
| R&D Expense | $28.9M | — | -13.4% |
| SG&A Expense | $17.2M | — | -20.4% |
| Operating Income | $21.1M | — | +1495.8% |
| Income Tax | $1.7M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $102.8M | +16.3% | -22.8% |
| Accounts Receivable | $124.7M | -25.1% | +19.5% |
| Current Assets | $267.4M | -8.9% | -2.3% |
| Total Assets | $1.61B | -2.4% | -2.6% |
| Current Liabilities | $299.9M | +1.8% | +15.0% |
| Long-term Debt |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $81.4M | — | +49.9% |
| Capital Expenditures | $614K | — | -64.3% |
| Investing Cash Flow | -$614K | — | +98.7% |
| Financing Cash Flow | -$65.9M | — | -3028.2% |
| Free Cash Flow | $80.8M | — | +53.6% |
| -62.9% |
| Net Income | $13.6M | — | +145.3% |
| EPS (Basic) | $0.13 | — | +160.0% |
| EPS (Diluted) | $0.12 | — | +140.0% |
| $262.8M |
| +23.1% |
| — |
| Total Liabilities | $623.4M | +7.6% | +9.4% |
| Stockholders' Equity | $970.4M | -8.1% | -9.5% |